Ocular Inflammation and Pain Following Cataract Surgery

Primary Investigator: Pedram Hamrah, MD

Title: A Phase 3, Multi-Center, Double-Masked, Vehicle-Controlled, Randomized, Parallel-Group Study to Assess Loteprednol Etabonate Ophthalmic Gel, 0.38% (BID and TID) versus Vehicle Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery

Sponsor: Bausch & Lomb

Inclusion Criteria:  Be a candidate for routine, uncomplicated cataract surgery, have potential postoperative pin-holed Snellen visual acuity (VA) of at least 20/200 in the study eye at visit 1 and at least 20/200 in the fellow eye

Study Length and Visits:  7 study visits over approximately 4 weeks

Age Range: > 18 years old,

Payment: $20 for Day 2 visit, $100 for Day 1, 3, 4, 5, 6, and 7 visits

Contact: Mildred Commodore, 617-636-1051 or Carly Satsuma, 617-636-5489